Q32 Bio, Inc. (QTTB)
8.74
+0.40
(+4.80%)
USD |
NASDAQ |
Oct 12, 16:00
8.74
0.00 (0.00%)
After-Hours: 16:15
Q32 Bio Free Cash Flow (Quarterly) : -3.075M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.075M |
| March 31, 2026 | -6.343M |
| December 31, 2025 | -6.18M |
| September 30, 2025 | -4.23M |
| June 30, 2025 | -10.65M |
| March 31, 2025 | -12.48M |
| December 31, 2024 | -11.43M |
| September 30, 2024 | -19.58M |
| June 30, 2024 | -22.23M |
| March 31, 2024 | -14.55M |
| December 31, 2023 | -10.72M |
| September 30, 2023 | 15.90M |
| June 30, 2023 | -11.37M |
| March 31, 2023 | -12.50M |
| December 31, 2022 | -27.21M |
| September 30, 2022 | -24.94M |
| June 30, 2022 | -30.97M |
| March 31, 2022 | -31.83M |
| Date | Value |
|---|---|
| December 31, 2021 | -30.77M |
| September 30, 2021 | -25.86M |
| June 30, 2021 | -24.88M |
| March 31, 2021 | -30.64M |
| December 31, 2020 | -12.57M |
| September 30, 2020 | -29.04M |
| June 30, 2020 | -28.58M |
| March 31, 2020 | -27.88M |
| December 31, 2019 | -30.06M |
| September 30, 2019 | -27.21M |
| June 30, 2019 | -27.59M |
| March 31, 2019 | -28.34M |
| December 31, 2018 | -24.01M |
| September 30, 2018 | -18.52M |
| June 30, 2018 | -12.90M |
| March 31, 2018 | -12.08M |
| December 31, 2017 | 21.71M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -84.92M |
| Beam Therapeutics, Inc. | -68.51M |
| Prime Medicine, Inc. | -41.09M |
| Prelude Therapeutics, Inc. | -15.57M |
| Twist Bioscience Corp. | -8.648M |